These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 33412815)

  • 1. [Temporal variations in excess mortality during phase 1 and phase 2 of the COVID-19 epidemic in Italy].
    Michelozzi P; de' Donato F; De Sario M; Scortichini M; Stafoggia M; Noccioli F; Andrianou X; Boros S; Del Manso M; Fabiani M; Urdiales AM; Pezzotti P; Rossi P; Rezza G; Costa G; Davoli M
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):236-243. PubMed ID: 33412815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the Overall Mortality during the COVID-19 Outbreak in the Provinces of Milan and Lodi (Lombardy Region, Northern Italy).
    Sandrini M; Andreano A; Murtas R; Tunesi S; Riussi A; Guido D; Greco MT; Gattoni ME; Gervasi F; Consolazio D; Adreoni L; Decarli A; Russo AG
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):244-251. PubMed ID: 33412816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A municipality-level analysis of excess mortality in Italy in the period January-April 2020.
    Biggeri A; Lagazio C; Catelan D; Barbone F; Braga M
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):297-306. PubMed ID: 33412822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gender and age factors affecting the mortality during the COVID-19 epidemic in Italy].
    Azzolina D; Magnani C; Gallo E; Ferrante D; Gregori D
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):252-259. PubMed ID: 33412817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal dynamics in total excess mortality and COVID-19 deaths in Italian cities.
    Michelozzi P; de'Donato F; Scortichini M; Pezzotti P; Stafoggia M; De Sario M; Costa G; Noccioli F; Riccardo F; Bella A; Demaria M; Rossi P; Brusaferro S; Rezza G; Davoli M
    BMC Public Health; 2020 Aug; 20(1):1238. PubMed ID: 32795276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sex/gender differences in COVID-19 lethality: what the data say, and do not say].
    Mangia C; Russo A; Civitelli S; Gianicolo EAL
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):400-406. PubMed ID: 33412835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doubled mortality rate during the COVID-19 pandemic in Italy: quantifying what is not captured by surveillance.
    Odone A; Delmonte D; Gaetti G; Signorelli C
    Public Health; 2021 Jan; 190():108-115. PubMed ID: 33412438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Did social isolation during the SARS-CoV-2 epidemic have an impact on the lifestyles of citizens?
    Ferrante G; Camussi E; Piccinelli C; Senore C; Armaroli P; Ortale A; Garena F; Giordano L
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):353-362. PubMed ID: 33412829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classification of weekly provincial overall age- and gender-specific mortality patterns during the COVID-19 epidemics in Italy.
    Kejžar N; Lusa L
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):271-281. PubMed ID: 33412819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Describing the epidemic trends of COVID-19 in the area covered by Agency for Health Protection of the Metropolitan Area of Milan.
    Tunesi S; Murtas R; Riussi A; Sandrini M; Andreano A; Greco MT; Gattoni ME; Guido D; Gervasi F; Consolazio D; Adreoni L; Decarli A; Bergamaschi W; Russo AG
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):95-103. PubMed ID: 33412799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excess mortality during the COVID-19 outbreak in Italy: a two-stage interrupted time-series analysis.
    Scortichini M; Schneider Dos Santos R; De' Donato F; De Sario M; Michelozzi P; Davoli M; Masselot P; Sera F; Gasparrini A
    Int J Epidemiol; 2021 Jan; 49(6):1909-1917. PubMed ID: 33053172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Impact of the COVID-19 epidemic in Friuli Venezia Giulia Region (Northern Italy): assessment of factors associated with the risk of death by competing risks analysis].
    Castriotta L; Rosolen V; Barbiero F; Tomietto M; de Dottori M; Barbone F; Zamaro G
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):128-135. PubMed ID: 33412803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Impact of the COVID-19 epidemic on total and cause-specific mortality in Rome (Italy) in 2020].
    Asta F; Michelozzi P; De Sario M; Santelli E; Bauleo L; Cozzi I; Vairo F; Davoli M; Porta D
    Epidemiol Prev; 2022; 46(1-2):59-67. PubMed ID: 35354268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying the Italian provinces with increased mortality during COVID-19 epidemics using the data made available by the Italian National Institute of Statistics. A methodological challenge.
    Lusa L
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):260-270. PubMed ID: 33412818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Excess mortality risk in nursing care homes before and during the COVID-19 outbreak in Mantua and Cremona provinces (Lombardy Region, Northern Italy)].
    Ballotari P; Guarda L; Giacomazzi E; Ceruti A; Gatti L; Ricci P
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):282-287. PubMed ID: 33412820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the excess mortality and factors associated with deaths from COVID-19 versus other causes in Central Tuscany (Italy) in 2020.
    Levi M; Cipriani F; Romeo G; Balzi D
    Epidemiol Prev; 2021; 45(6):496-503. PubMed ID: 35001596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excess Mortality in Italy During the COVID-19 Pandemic: Assessing the Differences Between the First and the Second Wave, Year 2020.
    Dorrucci M; Minelli G; Boros S; Manno V; Prati S; Battaglini M; Corsetti G; Andrianou X; Riccardo F; Fabiani M; Vescio MF; Spuri M; Urdiales AM; Martina DM; Onder G; Pezzotti P; Bella A
    Front Public Health; 2021; 9():669209. PubMed ID: 34336767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-COVID-19 excess deaths by age and gender in the United States during the first three months of the COVID-19 pandemic.
    Jacobson SH; Jokela JA
    Public Health; 2020 Dec; 189():101-103. PubMed ID: 33197730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
    Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis and future scenarios of the SARS-CoV-2 epidemic in Tuscany Region (Central Italy)].
    Cereda G; Viscardi C; Gottard A; Mealli F; Baccini M
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):120-127. PubMed ID: 33412802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.